South Jersey women forced to find alternatives due to nationwide shortage of estrogen patches
The shortage comes with an increase in demand after the FDA lifted the black box warnings on hormone replacement therapy in November.
Watch CBS News
The shortage comes with an increase in demand after the FDA lifted the black box warnings on hormone replacement therapy in November.
The Food and Drug Administration says the "black box" warnings on some hormone-based drugs used to treat menopause symptoms are uncalled for and will be removed.
In an interview with CBS News, FDA Commissioner Dr. Marty Makary explains what went into the decision to drop the most serious warnings on hormone therapy for menopause.
The safety of hormone therapy for menopause symptoms such as hot flashes and night sweats depends on when it's started, new research indicates. Reporter Stephanie Stahl has the latest.
Research on hormone therapy for women going through menopause has changed over the past two decades. Here's what to know as the FDA weighs removing health warnings on some treatments.
More than 75% of woman experience menopause-related hot flashes during their lives.
A landmark study published in JAMA in 2002 found a small increased risk of heart disease and breast cancer in women taking hormones.
Stephanie Stahl reports.
Stephanie Stahl reports.
